HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) is
pleased to announce that the leading independent proxy advisors,
Institutional Shareholder Services ("
ISS") and
Glass, Lewis & Co. ("
Glass Lewis"), have
recommended that shareholders of HEXO
("
Shareholders") vote
FOR the
Transaction Resolution and
FOR the Financing
Resolution, in advance of the upcoming Meeting of Shareholders to
be held on August 25, 2021. The meeting is being held in connection
with HEXO’s definitive share purchase agreement (the “
Share
Purchase Agreement”) to acquire all of the outstanding
shares of the entities that carry on the business of Redecan,
Canada’s largest privately-owned licensed producer, for a purchase
price of $925 million (the “
Transaction”). The
Transaction will create the Canadian market leader in adult-use
sales.
In reaching its recommendation, ISS noted that:
"The transaction makes strategic sense,” and that “The combined
entity will possess market leading share in a number of adult use
cannabis categories… allowing for HEXO to interact with and make
its value proposition to a larger number of consumers across a
greater spectrum of price points.” In supporting the Financing
Resolution, ISS further highlighted that the “approval of the
resolution will provide [HEXO] flexibility” with regard to how the
Senior Secured Convertible Note due 2023 may be settled, “allowing
for preservation of cash if necessary.”
Separately, Glass Lewis commented that “the
proposed acquisition is consistent with the competitive,
regulatory, economic and market conditions impacting the rapidly
evolving global cannabis industry” and “…the proposed acquisition
is strategically and financially compelling, and structured in a
fair and reasonable manner for HEXO and its shareholders”. In its
support for the Financing Resolution, Glass Lewis affirmed that
“the proposed secured note financing to complete the transaction is
in the best interests of shareholders.”
As independent proxy advisory firms, ISS and
Glass Lewis provide voting recommendations to some of the world's
largest institutional investors.
In welcoming ISS’ and Glass Lewis’ favourable
recommendations, HEXO CEO and co-founder Sebastien St-Louis,
commented: “We are pleased that ISS and Glass Lewis have
recommended in favour of all resolutions at our upcoming Meeting of
Shareholders. We unanimously recommend that our Shareholders
support this Transaction by voting FOR both
resolutions, to create a company with number one market-share in
Canadian recreational cannabis.”
Under the previously announced terms of the
Share Purchase Agreement, the $925 million purchase price will be
paid to the Redecan shareholders as follows:
-
$400 million of consideration due on closing paid in cash; and
-
$525 million of consideration due on closing paid through the
issuance of HEXO common shares at an implied price per share of
$7.53.
Transaction Highlights
The Transaction is expected to create the
Canadian market leader in recreational cannabis. The anticipated
benefits of the Transaction to HEXO Shareholders include:
-
Brand leader: Redecan’s product mix and
leading market share position across a number of key product
categories will complement HEXO’s already large suite of
sought-after brands across several products and price points.
-
Robust product portfolio: Following the
Transaction, HEXO is expected be a Canadian volume leader in dried
flower across premium, mainstream and value price points. The
Company is also expected to be the industry leader for
cannabis-infused beverages, while Redecan’s differentiated product
portfolio includes top selling oils and capsules, and market
leadership in the pre-roll category.
-
Product innovation: The newly combined
know-how further enables the development of higher potency and more
consistent products in key categories.
-
Accelerated path towards positive
EPS: Redecan has proven itself capable of
consistently delivering significant EBITDA with a low depreciable
capital base and zero debt.
-
Best-in-class production
capabilities: Redecan brings leading manufacturing,
automation and packaging capabilities, resulting in some of the
most consistent, efficiently produced and innovative products in
the industry. Its highly efficient proprietary pre-roll technology
has supported some of the highest product gross margins in the
industry.
-
Global growth opportunities: HEXO aims to
leverage Redecan’s unique pre-roll product, experience in
manufacturing, and well-known brands to expand market share across
Canada and further seize opportunities in the U.S. and Europe.
How to Vote
HEXO Shareholders are reminded that the deadline
to vote by proxy is fast approaching. Shareholders must
submit their votes by no later than 5:00 p.m. (EDT) on August 23,
2021. Your vote is important, regardless of how many HEXO
shares you own.
HEXO’s board of directors has unanimously
determined that the Transaction is in the best interests of
HEXO and its Shareholders. The board of directors unanimously
recommends that HEXO Shareholders vote FOR the Transaction
Resolution and the Financing Resolution. Voting is simple, and can
be done via the methods below:
Registered Shareholders
Registered Shareholders can vote their shares by
proxy over the internet, by entering the 12-digit control number
printed on the form of proxy at www.voteproxyonline.com.
Alternatively, registered Shareholders can complete their form of
proxy, and email it to TMXEInvestorServices@tmx.com.
Beneficial Shareholders
Beneficial Shareholders who hold their shares
through a broker or other intermediary, should follow the
instructions on the voting instruction form provided to them by
their broker or other intermediary in order to vote. Each
intermediary may have a different voting process.
Shareholder Questions
If you have any questions or if you require
assistance with voting, please contact HEXO’s strategic shareholder
advisor and proxy solicitation agent, Kingsdale Advisors, by
telephone at 1-866-229-8263 (toll-free in North America) or at
1-416-867-2272 outside of North America, or by email at
contactus@kingsdaleadvisors.com.
About HEXO
HEXO is an award-winning licensed producer of
innovative products for the global cannabis market. HEXO serves the
Canadian recreational market with a brand portfolio including HEXO,
UP Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands,
and the medical market in Canada, Israel and Malta. The Company
also serves the Colorado market through its Powered by HEXO®
strategy and Truss CBD USA, a joint-venture with Molson Coors. In
the event that the previously announced transactions to acquire
48North and Redecan close, HEXO expects to be the number one
cannabis products company in Canada by recreational market
share.
For more information, please visit
www.hexocorp.com.
Investor
Relations:invest@HEXO.comwww.hexocorp.com
Media Relations:(819)
317-0526media@hexo.com
Cautionary Note Regarding Forward-Looking
Statements
Certain information in this news release constitutes
forward-looking statements under applicable securities laws. Any
statements that are contained in this news release that are not
statements of historical fact are forward-looking statements.
Forward looking statements are often identified by terms such as
"may", "should", "anticipate", "expect", "potential", "believe",
"intend", “estimate” or the negative of these terms and similar
expressions. Forward-looking statements in this news release
include, but are not limited to: statements with respect to the
completion of the Transaction, the effect of the Transaction on
HEXO and its strategy going forward as well as the anticipated
benefits associated with the acquisition of Redecan, including, in
each case, the background and reasons summarized or described in
the statements noted by ISS and/or Glass Lewis.
Forward-looking statements are based on certain assumptions
regarding HEXO and Redecan, including the completion of the
Transaction, anticipated benefits from the Transaction, and
expected growth, results of operations, performance, industry
trends and growth opportunities. While HEXO considers these
assumptions to be reasonable, based on information currently
available, they may prove to be incorrect. Readers are cautioned
not to place undue reliance on forward-looking statements.
The assumptions of HEXO, although considered reasonable by them
at the time of preparation, may prove to be incorrect. In addition,
forward-looking statements necessarily involve known and unknown
risks, including, without limitation, risks associated with general
economic conditions; adverse industry events; future legislative,
tax and regulatory developments; inability to access sufficient
capital from internal and external sources, and/or inability to
access sufficient capital on favourable terms; the ability of HEXO
to implement its business strategies; competition; currency and
interest rate fluctuations and other risks. Among other things,
there can be no assurance that the Transaction will be completed or
that the anticipated benefits from the Transaction will be
achieved.
Readers are cautioned that the foregoing list is not exhaustive.
Readers are further cautioned not to place undue reliance on
forward-looking statements as there can be no assurance that the
plans, intentions or expectations upon which they are placed will
occur. Such information, although considered reasonable by
management at the time of preparation, may prove to be incorrect
and actual results may differ materially from those anticipated.
For more information on the risk, uncertainties and assumptions
that could cause anticipated opportunities and actual results to
differ materially, please refer to the public filings of HEXO which
are available on SEDAR at www.sedar.com, including the “Risk
Factors” section in HEXO’s Annual Information Form dated October
29, 2020 and the most recent management’s discussion and analysis
filed by HEXO.
Forward-looking statements contained in this news release are
expressly qualified by this cautionary statement and reflect our
expectations as of the date hereof, and thus are subject to change
thereafter. HEXO disclaims any intention or obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
Notice to U.S. Holders. Both HEXO and Redecan have been formed
outside of the United States. The Transaction will be subject to
disclosure requirements of Canada that are different from those of
the United States. Financial statements included in the documents,
if any, will be prepared in accordance with Canadian accounting
standards and may not be comparable to the financial statements of
United States companies. It may be difficult for a securityholder
in the United States to enforce his/her/its rights and any claim a
securityholder may have arising under U.S. federal securities laws,
since the companies are located in Canada, and some or all of their
officers or directors may be residents of Canada or another country
outside of the United States. A securityholder may not be able to
sue a Canadian company or its officers or directors in a court in
Canada or elsewhere outside of the United States for violations of
U.S. securities laws. It may be difficult to compel a Canadian
company and its affiliates to subject themselves to a U.S. court's
judgment.
Neither the TSX, nor NYSE accepts responsibility for the
adequacy or accuracy of this release.
HEXO (TSX:HEXO)
Historical Stock Chart
From Dec 2024 to Jan 2025
HEXO (TSX:HEXO)
Historical Stock Chart
From Jan 2024 to Jan 2025